Work for Deciphera Pharmaceuticals, Inc.?

Claim Your Profile

Deciphera Pharmaceuticals, Inc. Logo Image

Deciphera Pharmaceuticals, Inc.

Deciphera Pharmaceuticals, Inc. Banner Image

About Deciphera Pharmaceuticals, Inc.

201-500 Employees
Based in Waltham, Massachusetts

Deciphera is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. They are leveraging their proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from their platform in clinical studies, QINLOCKTM is Deciphera’s FDA-approved switch-control kinase inhibitor for the treatment of fourth-line gastrointestinal stromal tumor (GIST). QINLOCK is also approved for fourth-line GIST in Canada and Australia.

NASDAQ (See More NASDAQ Companies)
Biotechnology (See More Biotechnology Companies)
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol